CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 8-K Event Unregistered share sale
- 4 Grant or award Director acquired 26,667 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 16,667 shares (grant or award)
- 4 Open-market buy VP of Research and Development bought 4,245 shares at an average $4.56 ($19,349)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Unregistered share sale · Executive or director change
- 4 Gift CEO and Chairman of the Board gave 5,000 shares (gift)
- 4 Grant or award Director acquired 10,866 shares (grant or award)
- 4 Grant or award Director acquired 21,731 shares (grant or award)
Page 25 of 38 · 755 filings